Director AGUIAR ERIC 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000632
Director DANIELS RONALD J 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000631
Director Ellis Andrea 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000630
Director Hassan Fred 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000629
Director MOMTAZEE JAMES C 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000628
Director MCCORMICK FRANK 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000627
Director Dachille Douglas A. 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000626
Director Satvat Ali J. 🟢 acquired 9.3K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $68.92 Transaction Date: Jun 22, 2026 | Filing ID: 000625